Charcot foot and Charcot-Marie-Tooth. An update : Research Article

Alejandro L. Villalobos-Rodríguez

doi:10.58372/2835-6276.1052

Authors

Alejandro L. Villalobos-Rodríguez

DOI:

https://doi.org/10.58372/2835-6276.1052

Abstract

INTRODUCTION. Neuropathy or also called peripheral neuropathy is a disease that affects the nerves of the peripheral nervous system. The peripheral nervous system is a network of nerves that connects the central nervous system and the spinal cord. Neuropathy occurs when nerve cells, or neurons, present some alteration which interrupts the interconnection between each one, limiting neuronal electrical activity. Neuropathy can affect one nerve or a combination of nerves. Neuropathy is very common. It is estimated that about 25 to 30% of Americans will have neuropathy. Neuropathy occurs in 60 to 70% of the population suffering from DM2.

MATERIAL AND METHOD. An internet search was carried out in the Pubmed and Scielo databases and national journals related to the subject with the keywords type 1 and type 2 diabetes mellitus, Charcot foot and Charcot-Marie-Tooth, selecting 31 current references on both topics.

DISCUSSION. Charcot neuropathy is a disabling complication of DM. Its diagnosis implies a physical examination, anamnesis, supported by radiological studies that allow differentiating this complication from other disorders that affect the distal limbs in the same way, such as osteomyelitis. Initially, its opportune diagnosis allows establishing primary treatments with the purpose of avoiding the fearsome complications of the disease, leaving another type of treatment as a last option.

CONCLUSION. There are multiple diseases that affect the peripheral nervous system, but the two main ones are Charcot Foot and Charcot-Marie-Tooth disease.

References

Francisco J, Aguilera C, Reyes A, Charcot J-M. Charcot y su Legado a la Medicina. Gac Méd Méx. 2012; 148:321-6.

Lara-Aguilar RA, Juárez-Vázquez CI, Juárez-Rendón KJ, et al. Enfermedad de Charcot-Marie-Tooth: actualidad y perspectivas. Arch Neurocien. 2012; 17(2):110-8.

López-Gavito E, Parra-Téllez P, Vázquez-Escamilla J. La neuroartropatía de Charcot en el pie diabético. Acta Ortop Mex [Scielo]. 2016; 30(1):33-45.

Neuropatia 2022. Clevelandclinic.org. [citado el 27 de mayo de 2022]. Disponible en: http://www.clevelandclinic.org/health/shic/html/s14737.asp

Rubin M. Enfermedad de Charcot-Marie-Tooth. MSD, 2022.

Berciano J, Sevilla T, Casasnovas C, Sivera R, Vílchez JJ, Infante J, et al. Guía diagnóstica en el paciente con enfermedad de Charcot-Marie-Tooth. Neurol. 2012; 27(3):169-78.

Medina Gutiérrez R. Fisiopatología de la neuroartropatía de Charcot. Orthotips. 2019; 15(3):146-52.

Gerardo E, Gavito L. La neuroartropatía de Charcot en el pie diabético. Acta Ortop Mex. 2016; 30(1): Ene.-Feb: 33-45.

Pie Diabético: Epidemiologia [OrthoInfo]. Ulceras.net. [citado el 2 de marzo de 2022]. Disponible en: https://www.úlceras.net/monograficos/83/66/pie-diabetico-epidemiologia.html

Keays R. Diabetes. Curr Anaesth Crit Care. 2007; 18(2):69-75. [Internet]. 2007 [citado el 27 de enero de 2022]; 18(2):69–75.

Pie diabético (Charcot) (Diabetic Charcot Foot) - OrthoInfo - AAOS [Internet]. Aaos.org.

Orphanet: Enfermedad de Charcot Marie Tooth tipo 1 [Internet]. Orpha.net.

Apelqvist J, Bus SA, Hinchli RJ, Lipsky BA. Iwgdfguidelines.org.

Minchala-Urgilés RE, Ramírez-Coronel AA, Martínez-Suárez PC, Estrella-González M de los A. Diabetes Mellitus Tipo I, Pie de Charcot. Caso Clínico. Diab Int Endocrinol. 2020; 12(1): 54-8. Doi: http://doi.org/10.5281/zenodo.4381108

Lanzoni-Ortiz E, Soto-Taborda T, Valverde-Guevara CA. Pie de Charcot. Una revisión bibliográfica. Rev Cienc Sal. 2020; 3(5): 7 págs.

Cardona-Garbey DL, Vinent-Despaigne L, Cala-Cardona JC, Zaldívar-Álvarez E, Rodríguez-Salvá A. Pie de riesgo en personas con diabetes mellitus de tipo 2 en la Atención Primaria de Salud durante 2016. MEDISAN 2018; 21(5):518-18.

Lasalle Vignolo A. Enfermedad de Charcot de pie y tobillo en pacientes con diabetes Mellitus: análisis de las causas de re consultas en una Unidad de pie diabético hospitalaria. An Facultad Med (Univ Repúb Urug). 2022; 9(1): e204. Doi: 10.25184/anfamed2022v9n1a3

Waibel Felix WA, Berli Martin C, Gratwohl V, Sairanen VK, Kaiser D, Shin L, et al. Midterm Fate of the Contralateral Foot in Charcot Arthropathy. Foot Ankle Int. 2020 October; 41(10): 1181-9. Doi: 10.1177/1071100720937654

Griffiths DA, Kaminski MR. Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study. J Foot Ankle Res. 2021; 14:44. 12 pages. https://doi.org/10.1186/s13047-021-00477-5

Schade VL, Andersen ChA. A literature-based guide to the conservative and surgical management of the acute Charcot foot and ankle. Diabetic Foot & Ankle 2015; 6: 26627 - http://dx.Doi.org/10.3402/dfa.v6.26627

Keukenkamp R, Busch-Westbroek TE, Barn R, Woodburn J, Bus SA. Foot ulcer recurrence, plantar pressure and footwear adherence in people with diabetes and Charcot midfoot deformity: A cohort analysis. Diabet Med. 2021; 38:e14438. https://doi.org/10.1111/dme.14438

Thewjitcharoen Y, Sripatpong J, Parksook W, Krittiyawong S, Porramatikul S, Srikummoon T, et al. Salient features and outcomes of Charcot foot – An often-overlooked diabetic complication: A 17-year-experience at a diabetic center in Bangkok. J Clin Translat Endocrinol. 11 (2018) 1-6. https://doi.org/10.1016/j.jcte.2018.01.001

Yalcouyé A, Esoh K, Guida L, Wonkam A. Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review. J Peripher Nerv Syst. 2022; 27(2):100‐12. doi:10.1111/jns.12489

Rambelli C, Mazzoli D, Galletti M, Basini G, Zerbinati P, Prati P, et al. Foot Assessment Clinical Scales in Charcot-Marie-Tooth Patients: A Scoping Review. Front. Hum. Neurosci. 2022; 16:914340. Doi: 10.3389/fnhum.2022.914340

Redmond AC. The foot posture index Easy quantification of standing foot posture six item version FPI-6 user guide and manual. 2005.

Candayan A, Parman Y, Battaloğlu E. Clinical and Genetic Survey for Charcot-Marie-Tooth Neuropathy Based on the Findings in Turkey, a Country with a High Rate of Consanguineous Marriages. Balkan Med J.; 2022; 39(1):3-11. http://balkanmedicaljournal.org/

Schiavon CR, Shadel GS, Manor U Impaired Mitochondrial Mobility in Charcot-Marie-Tooth Disease. Front. Cell Dev. Biol. 2021; 9:624823. Doi: 10.3389/fcell.2021.624823

Stavrou M, Sargiannidou I, Georgiou E, Kagiava A, Kleopa KA. Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies. Int J Mol Sci. 2021; 22: 6048. https://doi.org/10.3390/ijms22116048

Pisciotta C, Saveri P, Pareyson D. Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future Perspectives. Brain Sci. 2021; 11:1447. https://doi.org/10.3390/brainsci11111447

Tao F, Beecham GW, Rebelo AP, Blanton SH, Moran JJ, López-Anido C, et al. Variation in SIPA1L2 Is Correlated with Phenotype Modification in Charcot- Marie-Tooth Disease Type 1A. Ann Neurol. 2019 March; 85(3): 316-30. Doi:10.1002/ana.25426.